ACE2: the molecular doorway to SARS-CoV-2
Open Access
- 30 December 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell & Bioscience
- Vol. 10 (1), 1-17
- https://doi.org/10.1186/s13578-020-00519-8
Abstract
The angiotensin-converting enzyme 2 (ACE2) is the host functional receptor for the new virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different cell types. Some factors that can affect the expression of the ACE2 are: sex, environment, comorbidities, medications (e.g. anti-hypertensives) and its interaction with other genes of the renin-angiotensin system and other pathways. Different factors can affect the risk of infection of SARS-CoV-2 and determine the severity of the symptoms. The ACE2 enzyme is a negative regulator of RAS expressed in various organ systems. It is with immunity, inflammation, increased coagulopathy, and cardiovascular disease. In this review, we describe the genetic and molecular functions of the ACE2 receptor and its relation with the physiological and pathological conditions to better understand how this receptor is involved in the pathogenesis of COVID-19. In addition, it reviews the different comorbidities that interact with SARS-CoV-2 in which also ACE2 plays an important role. It also describes the different factors that interact with the virus that have an influence in the expression and functional activities of the receptor. The goal is to provide the reader with an understanding of the complexity and importance of this receptor.Keywords
Funding Information
- Consejo Nacional de Ciencia y Tecnología, Mexico (Scholarship number 969754 to JACE)
This publication has 156 references indexed in Scilit:
- The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescentsBMC Medical Genetics, 2013
- Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled StudyPLOS ONE, 2013
- Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus EntryJournal of Virology, 2012
- ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic RetinopathyMolecular Therapy, 2012
- Lack of Association of ACE2 G8790A Gene Mutation with Essential Hypertension in the Chinese Population: A Meta-Analysis Involving 5260 SubjectsFrontiers in Physiology, 2012
- Macrophage Phenotype Modulation by CXCL4 in AtherosclerosisFrontiers in Physiology, 2012
- ACE2 and Diabetes: ACE of ACEs?Diabetes, 2010
- Changes in the renin angiotensin system during the development of colorectal cancer liver metastasesBMC Cancer, 2010
- Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical OutcomesJournal of Cardiac Failure, 2009
- Weight Loss and the Renin-Angiotensin-Aldosterone SystemHypertension, 2005